Long-Term Responders After Autologous Stem Cell Transplantation in Multiple Myeloma

Long-Term Responders After Autologous Stem Cell Transplantation in Multiple Myeloma

IntroductionMultiple myeloma (MM) is considered an incurable hematological neoplasm. For transplant-eligible patients, initial treatment includes an induction phase followed by an autologous stem cell transplantation (ASCT). Despite the introduction of several drugs in the past years, relapses still...

Full description

Bibliographic Details
Main Authors: Aina Oliver-Caldes, Juan Carlos Soler-Perromat, Ester Lozano, David Moreno, Alex Bataller, Pablo Mozas, Marta Garrote, Xavier Setoain, Juan Ignacio Aróstegui, Jordi Yagüe, Natalia Tovar, Raquel Jiménez, Luis Gerardo Rodríguez-Lobato, M. Teresa Cibeira, Laura Rosiñol, Joan Bladé, Manel Juan, Carlos Fernández de Larrea
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Oncology
Subjects:
multiple myeloma
long-term responders
autologous stem cell transplantation
positron emission tomography/computed tomography
oligoclonal bands
T cell clones
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.936993/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.936993/full

Similar Items